Brazilian registry of persons with hemophilia A receiving emicizumab (Emicizumab Cases, EMCase Project)
R. Camelo1, N. Dantas-Silva2, J. Alvares-Teodoro31Universidade Federal de Minas Gerais, Faculty of...
Read More
Category: BOCCADASSE 6sept
Nature of FVIII-containing immune complexes and induction of immune tolerance in patients with hemophilia A
Mélissa Bou Jaoudeh, Victoria Daventure, Sandrine Delignat, Angelina Mimoun, Sébastien...
Read More
The timing of initial exposures to FVIII treatment in nonsevere hemophilia A
A. Abdi1, F.R. Kloosterman1, C.L. Eckhardt1, C. Male2, G. Castaman3, K. Fischer4, E.A.M. Beckers5,...
Read More
Performance of a clinical risk prediction model for inhibitor formation in severe hemophilia
S. Hassan1, R. Palla2, C. Valsecchi3, I. Garagiola3, A. El-Beshlawy4, M. Elalfy5, V. Ramanan6, P....
Read More
rFVIIIFc for first-time immune tolerance induction (ITI) therapy: interim results from the global, prospective verITI-8 study
Lynn Malec1,a, Manuel Carcao2, Nisha Jain3, Mariya Spasova4, Dobrin Konstantinov5, Neha...
Read More